VivoRx Pharmaceuticals Inc., HemoCleanse Inc. deal

The companies agreed to develop a bioartificial liver device using VivoRx's HepatoRx porcine liver cells with HemoCleanse's BioLogic-DT liver assist device to treat acute liver failure. The BioLogic-D...